rts logo

BridgeBio Pharma Inc (BBIO) Is Down -31.06% in 2024 With Lots of Room to Run

BridgeBio Pharma Inc (NASDAQ: BBIO) is -31.06% lower on its value in year-to-date trading and has touched a low of $14.78 and a high of $44.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BBIO stock was last observed hovering at around $27.05 in the last trading session, with the day’s gains setting it 0.78%.

Currently trading at $27.83, the stock is -2.69% and 0.63% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.13 million and changing 2.88% at the moment leaves the stock -8.57% off its SMA200. BBIO registered 70.84% gain for a year compared to 6-month loss of -17.20%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -3.13% gain in the last 1 month and extending the period to 3 months gives it a -3.84%, and is -3.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.48% over the week and 4.96% over the month.

BridgeBio Pharma Inc (BBIO) has around 550 employees, a market worth around $5.21B and $218.60M in sales. Profit margin for the company is -246.23%. Distance from 52-week low is 88.35% and -37.21% from its 52-week high. The company has generated returns on investments over the last 12 months (-79.78%).

with sales reaching $3.57M over the same period.The EPS is expected to grow by 18.19% this year, but quarterly earnings will post 3,962.60% year-over-year.

BridgeBio Pharma Inc (BBIO) Top Institutional Holders

The shares outstanding are 175.08M, and float is at 140.10M with Short Float at 11.27%.

BridgeBio Pharma Inc (BBIO) Insider Activity

The most recent transaction is an insider sale by Scott Randal W.,the company’sDirector. SEC filings show that Scott Randal W. sold 1,500 shares of the company’s common stock on Jun 04 ’24 at a price of $31.30 per share for a total of $46950.0. Following the sale, the insider now owns 4000.0 shares.

BridgeBio Pharma Inc disclosed in a document filed with the SEC on Jun 03 ’24 that Scott Randal W. (Director) sold a total of 1,000 shares of the company’s common stock. The trade occurred on Jun 03 ’24 and was made at $28.84 per share for $28843.0. Following the transaction, the insider now directly holds 5500.0 shares of the BBIO stock.

Still, SEC filings show that on Mar 01 ’24, Scott Randal W. (Director) disposed off 2,500 shares at an average price of $34.00 for $85000.0. The insider now directly holds 6,500 shares of BridgeBio Pharma Inc (BBIO).

Related Posts